Navigation Links
Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications
Date:3/21/2008

NEW YORK, March 21 /PRNewswire/ -- Haymarket Media Inc. is now the publisher of two leading journals for cancer clinicians, The American Journal of Hematology/Oncology and Oncology Nursing News, under an agreement announced today. Both titles were previously published by U.S. HealthCare Communications, of Highland Park, NJ.

"We are very pleased to add a strong oncology presence to the Haymarket clinical family," said Lee Maniscalco, CEO. "The practical, clinical guidance these publications offer to their readers, and the wide variety of Continuing Education opportunities they provide throughout the year -- within the journals themselves, in special supplements, and in Web-based initiatives -- make this a perfect fit for Haymarket. The addition of these two publications is entirely consistent with our goal of expanding and enhancing learning opportunities for practicing cancer clinicians nationwide."

The American Journal of Hematology/Oncology (AJHO) reaches oncologists, hematologists, and other cancer clinicians nationwide. Each monthly issue offers concise summaries and expert commentaries on the peer-reviewed scientific literature and conference proceedings, so that the latest research findings can be applied in day-to-day patient care. The editorial board is headed by Lawrence N. Shulman, MD, Chief Medical Officer, Dana Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston; and Douglas J. Schwartzentruber, MD, Medical Director of the Goshen Center for Cancer Care, Goshen, Indiana. Marcus E. Randall, MD, Professor and Chair of Radiation Medicine at the University of Kentucky School of Medicine, Lexington, serves AJHO as Associate Editor for Radiation Oncology. Each issue of the journal offers Continuing Medical Education accredited by Harvard Medical School.

Oncology Nursing News (ONN) provides late-breaking clinical news and practical guidance to nurses, nurse practitioners, and physician assistants across all settings of cancer care and supportive services. ONN offers coverage from the most significant oncology meetings throughout the year, news of clinical relevance from the peer-reviewed literature, and how-to advice based on the clinical and management experiences of leading oncology nurses. The Editor in Chief is Regina Cunningham, PhD, RN, AOCN, Chief Nursing Officer of The Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick.

"We look forward to working with the staffs of these publications and the outstanding experts who serve on their editorial boards to bring the very best and latest information to the dedicated clinicians who care for cancer patients," said Maniscalco.

Haymarket Media Inc., based in New York City, publishes a variety of clinical journals and drug information digests for health professionals, including Monthly Prescribing Reference, Renal & Urology News, Cortlandt Forum (for primary-care physicians), The Clinical Advisor (for nurse practitioners and physician assistants), The Journal of the American Academy of Physician Assistants, McKnight's Long-Term Care News, and Assisted Living.


'/>"/>
SOURCE Haymarket Media Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... Groth Family Insurance, a Washington-based firm offering ... a charity drive to support the family of Cindy Hendrickson, a local mother ... On October 29th of this year, Cindy Hendrickson swerved to avoid an oncoming ...
(Date:12/9/2016)... Ohio (PRWEB) , ... December 09, 2016 , ... ... of miniature, folded, pharmaceutical inserts and outserts. As a means of expanding ... This addition will enable Flottman to individually code professional inserts (PIs) and patient ...
(Date:12/9/2016)... Yorktown Heights, NY (PRWEB) , ... December 09, 2016 , ... ... on Alcoholism and Drug Dependence, Inc. (NCADD) is recommending the film Whispering ... 29 states and the District of Columbia as an education tool in the war ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... An inventor ... amputees to safely ride all types of amusement park rides. , The patent-pending SAFETY ... unit is easy to use and could be set up in a matter of ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 Research ... Vaccines Market 2016-2020" report to their offering. ... The global travel vaccines market ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
Breaking Medicine Technology: